Potassium-Selective Nanoelectrode Arrays for Single-Cell Profiling of human iPSC-Derived Cardiomyocytes

The paper introduces KINESIS, a novel nanofabricated platform utilizing valinomycin-coated nanopillars to enable label-free, subcellular-resolution, and chemically specific monitoring of potassium dynamics in human iPSC-derived cardiomyocytes, overcoming the limitations of existing electrophysiological tools for cardiac disease modeling and drug screening.

Meganathan, D. P., Banzon, R., Casanova, A. + 10 more2026-02-18📄 pharmacology and toxicology

Novel Plasma Proteomics and Phosphoproteomics Platform Captures Pleiotropic Cardiometabolic Spectrum Effects of Semaglutide in Patients with T2D and Atherosclerosis: A Companion Diagnostic Pilot Study from the STOP (Semaglutide Treatment On coronary atherosclerosis Progression) Randomized Trial

This pilot study utilized a novel, high-depth plasma proteomics and phosphoproteomics platform on a subset of patients from the STOP trial to identify a comprehensive molecular signature of semaglutide's pleiotropic cardiometabolic effects, revealing thousands of differentially abundant proteins and phosphoproteins that elucidate the drug's underlying pathways and align with imaging biomarkers in patients with type 2 diabetes and atherosclerosis.

Manousopoulou, A., White, C. H., Hamal, S. + 3 more2026-02-18📄 pharmacology and toxicology

An Indian Diet Relevant Rat Screening Model for Hypertriglyceridemia Associated Fatty Liver

This paper presents a novel diet-induced rat screening model that mimics typical Indian cereal-rich, high-fat dietary patterns to reproducibly generate hypertriglyceridemia-associated fatty liver with minimal inflammation, offering a translationally relevant tool for prioritizing lipid-modulating interventions without proposing a new disease model or evaluating therapeutic efficacy.

K, S., Jadhav, P., Mehaboob, S. + 3 more2026-02-17📄 pharmacology and toxicology

Targeting epilepsy with photopharmacology in human brain tissue

This study demonstrates that while light-activated ion-channel blockers show variable efficacy in human versus mouse brain tissue, a newly developed caged propofol (CaP) robustly suppresses epileptiform activity across species, highlighting the critical need for early human model testing in photopharmacology to develop precision therapies for medically refractory epilepsy.

Baues, M., Elgokha, A., Nguyen, M. M. H. + 14 more2026-02-16📄 pharmacology and toxicology